2017 annual financial data
Coherus Oncology, Inc. 2017 Operating margin
Coherus Oncology, Inc. 2017 operating margin with verified reported values.
Direct answer
Operating margin was -14,918.77%.
Operating income was -232,136,000 USD and net income was -238,170,000 USD.
Operating cash flow was -200,286,000 USD.
Get free Coherus Oncology, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,556,000 USD
- Operating income
- -232,136,000 USD
- Net income
- -238,170,000 USD
- Operating cash flow
- -200,286,000 USD